27913-96-8 Usage
Uses
Used in Pharmaceutical Industry:
4-(1,1-Dioxothiomorpholino)benzaldehyde is utilized as an intermediate in the synthesis of various pharmaceuticals. Its unique structure, which includes a thiomorpholine ring and a dioxo group, makes it a key component in creating biologically active molecules that can be used in the development of new medications.
Used in Organic Compound Synthesis:
In the field of organic chemistry, 4-(1,1-Dioxothiomorpholino)benzaldehyde serves as an important intermediate for the synthesis of a range of organic compounds. Its versatility and reactivity contribute to the creation of diverse chemical entities that can be applied in various industrial and research settings.
Used in Medicinal Chemistry Research:
4-(1,1-Dioxothiomorpholino)benzaldehyde is also employed in medicinal chemistry research, where its unique structural features are leveraged to explore new avenues in drug discovery. Its potential to form biologically active molecules makes it a promising candidate for the development of innovative therapeutic agents.
Used in Chemical Research and Development:
Due to its distinctive structure and reactivity, 4-(1,1-Dioxothiomorpholino)benzaldehyde has potential applications in chemical research and development. It can be used to study reaction mechanisms, develop new synthetic routes, and create novel chemical entities with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 27913-96-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,9,1 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 27913-96:
(7*2)+(6*7)+(5*9)+(4*1)+(3*3)+(2*9)+(1*6)=138
138 % 10 = 8
So 27913-96-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO3S/c13-9-10-1-3-11(4-2-10)12-5-7-16(14,15)8-6-12/h1-4,9H,5-8H2
27913-96-8Relevant academic research and scientific papers
N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME
-
Page/Page column 210, (2021/02/12)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidin-2-one compounds (also referred to herein as "FRPPO compounds"), that, inter alia, inhibit glutaminyl-peptide cyclotransferase-like (isoQC) enzyme and/or glutaminyl-peptide cyclotransferase (QC) enzyme (e.g., inhibit or reduce or block the activity or function of isoQC and/or QC enzyme). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit isoQC and/or QC enzyme; to treat disorders that are ameliorated by the inhibition of isoQC and/or QC enzyme; to treat cancer, atherosclerosis, fibrotic diseases, infectious diseases, Alzheimer's disease, etc.
COMPOUNDS AND METHOD OF USE
-
Paragraph 1357, (2019/09/06)
This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.
Copolymerizable methine and anthraquinone compounds and articles containing them
-
Page/Page column 25, (2008/06/13)
This invention relates to polymerizable ultraviolet light absorbers and yellow colorants and their use in ophthalmic lenses. In particular, this invention relates to polymerizable ultraviolet light absorbing methine compounds and yellow compounds of the methine and anthraquinone classes that block ultraviolet light and/or violet-blue light transmission through ophthalmic lenses.
